What right does a teenager have to confidential health care? What influence does HIPAA have on that right? How you apply the answers in your practice could determine whether an adolescent seeks health services—or forgoes necessary care.
The scientific evidence to date-including the authors' recent RCT-says no. Were EC to be available over-the-counter, it would not encourage risky sex nor increase rates of STI.
Urinary incontinence can often be successfully created without referral, but first ob/gyns need to broach the subject! Two experts tell how to evaluate this widespread condition.
Nearly twice as many women as men suffer from clinical depression, and up to 50% of ob/gyn patients have the. disorder or its symptoms. Since you may be the only clinician many of these women see, you're uniquely positioned to detect its presence and steer patients toward appropriate treatment.
Many adolescents and young adult women experience physical or sexual violence perpetrated by someone close. Knowledge of risk factors, and sequelae associated with interpersonal violence and of screening methods to detect it can help the ob/gyn identify potential victims of assault. Careful management and referral of victims is critical and anticipatory guidance also is advised.
Most lesbian patients hesitate to reveal their sexual orientation, even though you need that information to deliver targeted health care. Creating a nonjudgmental office environment can encourage trust and disclosure, helping you to better address their unique health needs.
Tational decision-making and raging adolescent hormones do sound like strange bedfellows. But research reveals some ways ob/gyns can help teens make wiser choices-and grow into healthy sexual adults.
Venlafaxine is the most studied and most effective nonhormonal therapy for hot flashes in the US. Experience with this drug and anecdotal and pilot data have prompted investigation of similar agents. The optimal agent for relief of menopausal symptoms remains to be determined.
Unopposed oestrogen replacement therapy increases the risk of endometrial cancer in post-menopausal women. However, the addition of progestogen to the oestrogen therapy reduces the risk of endometrial carcinoma by preventing and effectively treating hyperplasia of the endometrium. In a 5-yr prospective study with a further 4 yr of follow-up (1975–1983), 31 adenocarcinomas of the endometrium were detected over 27243 patient-years of observation, for an incidence of 113.8:100000 women. The first report on the results of the study appeared in 1978; this paper presents further results.
